M. Zhao - The First Affiliated Hospital, China Medical University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 8 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients with Advanced Non-Small Cell Lung Cancer: Results from a Phase 2 Pivotal Study

Q. Zhou, X. Meng,L. Sun,D. Huang, N. Yang, Y. Yu,M. Zhao,W. Zhuang, Y. Hu, Y. Pan, M. Sun,J. Shan,R-H. Guo,Q. Chu, C. Xu, J. Lin, J. Huang, M. Huang, Y. Shen,Y-L. Wu

Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer (2024)

引用0浏览0WOS引用

P2.08-01 TROPION-Lung08: Datopotamab Deruxtecan Plus Pembrolizumab in Untreated Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC)

C. Zhou,B.P. Levy,J. Sands,S. Parakh,S. Sugawara,K. Syrigos, J.S. Ahn,M. Zhao, C.-C. Lin,E. Felip,F. Cappuzzo,M. Reck,J.C.H. Yang, R. Joseph, S. Rawat, J. Xie,I. Okamoto

Journal of Thoracic Oncologyno. 11 (2023): S327-S328

引用0浏览0引用

LBA69 Aumolertinib Plus Apatinib Versus Aumolertinib As First-Line Treatment in Patients with EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Multicenter Study

Y. Hu, F. Zhang,M. Zhao,Z. Zheng, H. Zhang, T. Jiang, Z. Liu, J. Wen, X. Gan, H. Wang, L. Wu,S. Cang, J. Zhao, X. Li, L. Peng, Z. Fan, G. Shen, Q. Zhou, J. Zou

Annals of Oncology (2023): S1312-S1312

引用0浏览0引用

A Phase II Trial Assessing the Safety and Efficacy of Tislelizumab Combined with Chemotherapy and Autologous NK Cells in Patients with ES-SCLC